Skip to Content

GS TEW 50 mg (Tafinlar 50 mg)

Generic Name: dabrafenib

Pill with imprint GS TEW 50 mg is Red, Capsule-shape and has been identified as Tafinlar 50 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of melanoma, metastatic; non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS TEW 50 mg

Tafinlar

Generic Name:
dabrafenib
Imprint:
GS TEW 50 mg
Strength:
50 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
National Drug Code (NDC):
00173-0846

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide